Science Explorer Back to mapMap

Most cited papers from Infectious Diseases Institute

What are the most cited papers from Infectious Diseases Institute?

The most cited paper from Infectious Diseases Institute is "Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA" (Sahil Loomba, Alexandre de Figueiredo, Simon J. Piatek et al., 2021), with 1,880 citations. Next come "Telaprevir for Retreatment of HCV Infection" (1,546) and "Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study" (1,211).

Showing 50 of 60 papers. Every paper with more than 161 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA Sahil Loomba, Alexandre de Figueiredo, Simon J. Piatek et al. · Nature Human Behaviour Open access 5 Feb 2021 1,880
2 Telaprevir for Retreatment of HCV Infection Stefan Zeuzem et al. · New England Journal of Medicine Open access 22 Jun 2011 1,546
3 Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study Alexandre de Figueiredo, Clarissa Simas, Emilie Karafillakis et al. · The Lancet Open access Sep 2020 1,211
4 Quantitative and stoichiometric analysis of the microRNA content of exosomes John R. Chevillet, Qing Hua Kang, Ingrid K. Ruf et al. · Proceedings of the National Academy of Sciences Open access 29 Sep 2014 1,122
5 Proviral silencing in embryonic stem cells requires the histone methyltransferase ESET Toshiyuki Matsui, Danny Leung, Hiroki Miyashita et al. · Nature Open access 17 Feb 2010 843
6 Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings Graeme Meintjes, Stephen D Lawn, Fabio Scano et al. · The Lancet Infectious Diseases Open access 22 Jul 2008 749
7 Clinical use of dendritic cells for cancer therapy Sébastien Anguille, Evelien Smits, Eva Lion et al. · The Lancet Oncology 25 May 2014 707
8 Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey Ann Versporten et al. · The Lancet Global Health Open access126 authors 23 Apr 2018 703
9 Ebola virus disease Shevin T. Jacob, Ian Crozier, William A. Fischer et al. · Nature Reviews Disease Primers ReviewOpen access 20 Feb 2020 681
10 The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis Radha Rajasingham, Nelesh Premapragasan Govender, Alexander Jordan et al. · The Lancet Infectious Diseases Open access 29 Aug 2022 633
11 Progress in Alternative Strategies to Combat Antimicrobial Resistance: Focus on Antibiotics Jayaseelan Murugaiyan et al. · Antibiotics Open access 4 Feb 2022 563
12 Persistence of Ebola Virus in Ocular Fluid during Convalescence Jay B. Varkey, Jessica G. Shantha, Ian Crozier et al. · New England Journal of Medicine Open access 7 May 2015 475
13 Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape Natalie I Mazur et al. · The Lancet Infectious Diseases Open access 8 Aug 2022 453
14 Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial Dafna Yahav et al. · Clinical Infectious Diseases Open access 7 Dec 2018 433
15 Dynamic Epidemiological Models for Dengue Transmission: A Systematic Review of Structural Approaches Mathieu Andraud, Niel Hens, Christiaan Marais et al. · PLoS ONE ReviewOpen access 6 Nov 2012 340
16 Epidemiology and Microbiology of Surgical Wound Infections Andrea Giacometti, Oscar Cirioni, Anna Maria Schimizzi et al. · Journal of Clinical Microbiology Open access Feb 2000 331
17 The Worldwide Antibiotic Resistance and Prescribing in European Children (ARPEC) point prevalence survey: developing hospital-quality indicators of antibiotic prescribing for children Ann Versporten, Julia Anna Bielicki, Nico Drapier et al. · Journal of Antimicrobial Chemotherapy Open access 8 Jan 2016 326
18 Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study Nathan C. Bahr et al. · The Lancet Infectious Diseases Open access 15 Sep 2017 325
19 Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM Christina C. Chang et al. · The Lancet Infectious Diseases Open access 9 Feb 2024 323
20 Hepatitis B and the Need for a Booster Dose Elke E. Leuridan, Pierre Van Damme · Clinical Infectious Diseases 7 Jun 2011 321
21 Rotavirus disease and vaccination: Impact on genotype diversity Jelle Matthijnssens, Joke Bilcke, Max Ciarlet et al. · Future Microbiology Dec 2009 320
22 Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions Lewis John Haddow, Robert Colebunders, Graeme Meintjes et al. · The Lancet Infectious Diseases Open access 26 Oct 2010 306
23 Antibiotic use in eastern Europe: a cross-national database study in coordination with the WHO Regional Office for Europe Ann Versporten, Ganna Bolokhovets, Lilit Ghazaryan et al. · The Lancet Infectious Diseases Open access 21 Mar 2014 290
24 Early waning of maternal measles antibodies in era of measles elimination: longitudinal study Elke E. Leuridan, Niel Hens, Veronik Hutse et al. · BMJ Open access 13 May 2010 284
25 In vivo and In vitro Interactions between Pseudomonas aeruginosa and Staphylococcus spp. An Hotterbeekx, Samir Kumar‐Singh, Herman Goossens et al. · Frontiers in Cellular and Infection Microbiology Open access 3 Apr 2017 283
26 Penetration of vancomycin into human lung tissue Mario Cruciani, Giorgio Gatti, Luca Lazzarini et al. · Journal of Antimicrobial Chemotherapy Nov 1996 266
27 Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda Jessica H. Oyugi, Jayne Byakika-Tusiime, Kathleen E. Ragland et al. · AIDS 23 Apr 2007 262
28 The French Connection: The First Large Population-Based Contact Survey in France Relevant for the Spread of Infectious Diseases Guillaume Béraud, Sabine Kazmercziak, Philippe Beutels et al. · PLoS ONE Open access 15 Jul 2015 252
29 Determinants of male involvement in the prevention of mother-to-child transmission of HIV programme in Eastern Uganda: a cross-sectional survey Robert Byamugisha, James Kashugyera Tumwine, Nulu Semiyaga et al. · Reproductive Health Open access 23 Jun 2010 248
30 Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus Kevin B. Walsh, John Ross Teijaro, Peter R. Wilker et al. · Proceedings of the National Academy of Sciences Open access 29 Jun 2011 237
31 An analysis of existing national action plans for antimicrobial resistance—gaps and opportunities in strategies optimising antibiotic use in human populations Esmita Charani, Marc Mendelson, Scott J C Pallett et al. · The Lancet Global Health Open access 2 Feb 2023 232
32 Lessons from a decade of individual-based models for infectious disease transmission: a systematic review (2006-2015) Lander Willem, Frederik Verelst, Joke Bilcke et al. · BMC Infectious Diseases ReviewOpen access 11 Sep 2017 231
33 CD70: An emerging target in cancer immunotherapy Julie Jacobs, Vanessa Deschoolmeester, Karen Zwaenepoel et al. · Pharmacology & Therapeutics Open access 26 Jul 2015 228
34 Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis Joseph N Jarvis et al. · LSTM Online Archive (Liverpool School of Tropical Medicine) 24 Mar 2022 219
35 Efficacy and Safety of a COVID-19 Inactivated Vaccine in Healthcare Professionals in Brazil: The PROFISCOV Study Ricardo Palácios et al. · SSRN Electronic Journal PreprintOpen access 2021 217
36 Predictors of Long-Term Viral Failure Among Ugandan Children and Adults Treated With Antiretroviral Therapy Moses Robert Kamya, Harriet Mayanja‐Kizza, Andrew Kambugu et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes 10 Sep 2007 211
37 Bisphosphonates for cancer treatment: Mechanisms of action and lessons from clinical trials Heleen H. Van Acker, Sébastien Anguille, Yannick Willemen et al. · Pharmacology & Therapeutics 23 Nov 2015 207
38 Assessment of Second-Line Antiretroviral Regimens for HIV Therapy in Africa Nicholas I. Paton et al. · New England Journal of Medicine Open access 11 Jul 2014 205
39 Increased Antifungal Drug Resistance in Clinical Isolates of Cryptococcus neoformans in Uganda Kyle D. Smith et al. · Antimicrobial Agents and Chemotherapy Open access Sep 2015 197
40 The Effect of Therapeutic Lumbar Punctures on Acute Mortality From Cryptococcal Meningitis Melissa A R Rolfes, Kathy Huppler Hullsiek, Joshua Rhein et al. · Clinical Infectious Diseases Open access 23 Jul 2014 194
41 Regulatory T Cells and Human Disease Nathalie Cools, Peter Ponsaerts, Viggo F. Van Tendeloo et al. · Clinical and Developmental Immunology Open access 2007 190
42 Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults María Ángeles Marcos, M. T. Jiménez de Anta, Jordi Puig de la Bellacasa et al. · European Respiratory Journal Open access Feb 2003 188
43 Assessment of Inflammatory Hematological Ratios (NLR, PLR, MLR, LMR and Monocyte/HDL–Cholesterol Ratio) in Acute Myocardial Infarction and Particularities in Young Patients Bogdan-Sorin Tudurachi, Larisa Anghel, Andreea Tudurachi et al. · International Journal of Molecular Sciences Open access 21 Sep 2023 187
44 Dolutegravir or Darunavir in Combination with Zidovudine or Tenofovir to Treat HIV Nicholas Iain Paton, Joseph Musaazi, Cissy M Kityo et al. · New England Journal of Medicine Open access 21 Jul 2021 187
45 Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma Gils Roex, Marijke Timmers, Kristien Wouters et al. · Journal of Hematology & Oncology Open access Dec 2020 187
46 The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance Houriiyah Tegally et al. · Science Open access1,824 authors 15 Sep 2022 184
47 Validation of a core outcome measure for palliative care in Africa: the APCA African Palliative Outcome Scale Richard Harding, Lucy Ellen Selman, Godfrey Agupio et al. · Health and Quality of Life Outcomes Open access 2010 183
48 Severe Sepsis in Two Ugandan Hospitals: a Prospective Observational Study of Management and Outcomes in a Predominantly HIV-1 Infected Population Shevin T. Jacob, Christopher Charles Moore, Patrick Banura et al. · PLoS ONE Open access 10 Nov 2009 183
49 Pertussis vaccination during pregnancy in Belgium: Results of a prospective controlled cohort study Kirsten Maertens, Raïssa Nadège Caboré, Kris Huygen et al. · Vaccine 17 Nov 2015 182
50 Lower Clinical Effectiveness of Oseltamivir against Influenza B Contrasted with Influenza A Infection in Children Norio Sugaya, Keiko Mitamura, Masahiko Yamazaki et al. · Clinical Infectious Diseases 19 Dec 2006 182

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.